ALL and AML Marrow Biopsy Donor Patients: Clinical Observations
| Patient No. . | Sex/Age (yr) . | Diagnosis . | Risk Factor Level . | Evolution . |
|---|---|---|---|---|
| R19 | M/9 | Pre-pre-B-ALL | High | Relapse after 6 mo |
| R20 | M/3 | Pre-pre-B-ALL (first relapse) | Standard | Relapse after 3 yr; alloBMT |
| R28 | M/5.5 | Pre-pre-B-ALL | Standard | CCR |
| R29 | F/5 | Pre-pre-B-ALL | Standard | CCR |
| R31 | M/12 | AML (first relapse) | High | Death 16 mo after first relapse |
| R35 (relapsed R19) | M/9 | Pre-pre-B-ALL | High | Death 8 mo after first relapse |
| R36 | M/4 | Pre-pre-B-ALL | Standard | CCR |
| R38 | F/15 | AML | High | AlloBMT; CCR |
| R39 | F/8 | Pre-pre-B-ALL (first relapse) | Standard | AlloBMT; CCR |
| R41 | M/3.5 | Pre-pre-B-ALL | Standard | CCR |
| R43 | M/2 | Pre-pre-B-ALL | Standard | CCR |
| R44 | M/2 | Pre-pre-B-ALL | High | CCR |
| R46 | F/3.5 | AML-2 | High | CCR |
| R48 | F/14 | ALL | Standard | CCR |
| R49 | M/6 | Pre-pre-B-ALL | Standard | CCR |
| Patient No. . | Sex/Age (yr) . | Diagnosis . | Risk Factor Level . | Evolution . |
|---|---|---|---|---|
| R19 | M/9 | Pre-pre-B-ALL | High | Relapse after 6 mo |
| R20 | M/3 | Pre-pre-B-ALL (first relapse) | Standard | Relapse after 3 yr; alloBMT |
| R28 | M/5.5 | Pre-pre-B-ALL | Standard | CCR |
| R29 | F/5 | Pre-pre-B-ALL | Standard | CCR |
| R31 | M/12 | AML (first relapse) | High | Death 16 mo after first relapse |
| R35 (relapsed R19) | M/9 | Pre-pre-B-ALL | High | Death 8 mo after first relapse |
| R36 | M/4 | Pre-pre-B-ALL | Standard | CCR |
| R38 | F/15 | AML | High | AlloBMT; CCR |
| R39 | F/8 | Pre-pre-B-ALL (first relapse) | Standard | AlloBMT; CCR |
| R41 | M/3.5 | Pre-pre-B-ALL | Standard | CCR |
| R43 | M/2 | Pre-pre-B-ALL | Standard | CCR |
| R44 | M/2 | Pre-pre-B-ALL | High | CCR |
| R46 | F/3.5 | AML-2 | High | CCR |
| R48 | F/14 | ALL | Standard | CCR |
| R49 | M/6 | Pre-pre-B-ALL | Standard | CCR |
Abbreviations: CCR, continuous complete remission; BMT, BM transplantation.